Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Koenig, W.
Right arrow Articles by Pepys, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koenig, W.
Right arrow Articles by Pepys, M. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Am J Epidemiol 2003; 158:357-364.
Copyright © 2003 by Johns Hopkins Bloomberg School of Public Health


ORIGINAL CONTRIBUTIONS

Refinement of the Association of Serum C-reactive Protein Concentration and Coronary Heart Disease Risk by Correction for Within-Subject Variation over Time

The MONICA Augsburg Studies, 1984 and 1987

Wolfgang Koenig1 , Malte Sund2, Margit Fröhlich1, Hannelore Löwel3, Winston L. Hutchinson4 and Mark B. Pepys4

1 Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany.
2 MEDIS Institute, GSF-National Research Center for Environment and Health, Neuherberg, Germany.
3 Institute of Epidemiology, GSF-National Research Center for Environment and Health, Neuherberg, Germany.
4 Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, London, United Kingdom.

The authors sought to assess the repeatability of measurements of C-reactive protein, an independent predictor of coronary heart disease, in a large cohort of apparently healthy men and to correct earlier estimates of the association of C-reactive protein and coronary heart disease for the measurement error in this protein. They measured C-reactive protein by a high-sensitivity assay in 936 men aged 45–64 years in the MONICA (Monitoring of Trends and Determinants in Cardiovascular Disease) Augsburg cohort in 1984–1985 and remeasured it 3 years later. All men were subjected to an 8-year follow-up of their cardiovascular status. The analytical variation of the assay was small, with the analytical variance component at 1 percent of the within-subject variance component, a repeatability coefficient of 25 percent, and a reliability coefficient of 1.00. In contrast, the within-subject variation of C-reactive protein corresponded to a repeatability coefficient of 740 percent and a reliability coefficient of 0.54, indicating considerable within-subject variation. Based on the authors’ estimates, three serial determinations of C-reactive protein should be done to achieve a reliability of 0.75, the value they found for total cholesterol. Correcting the hazard ratios in their original analysis of the association of coronary heart disease and high-sensitivity-assay C-reactive protein for the measurement error in C-reactive protein and covariables leads to a considerably larger estimate. The results suggest that the true association between C-reactive protein and cardiovascular risk is underestimated by a single C-reactive protein determination, and that several serial C-reactive protein measurements should be taken.

coronary disease; inflammation; predictive value of tests; proteins

Abbreviations: Abbreviations: CI, confidence interval; MONICA, Monitoring of Trends and Determinants in Cardiovascular Disease; VCa, analytical variance component; VCb, between-subject variance component; VCw, within-subject variance component.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
D. I. Buckley, R. Fu, M. Freeman, K. Rogers, and M. Helfand
C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force
Ann Intern Med, October 6, 2009; 151(7): 483 - 495.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
R. E. Marioni, M. C. Stewart, G. D. Murray, I. J. Deary, F. G. R. Fowkes, G. D. O. Lowe, A. Rumley, and J. F. Price
Peripheral Levels of Fibrinogen, C-Reactive Protein, and Plasma Viscosity Predict Future Cognitive Decline in Individuals Without Dementia
Psychosom Med, October 1, 2009; 71(8): 901 - 906.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
D. B Panagiotakos, K. Dimakopoulou, K. Katsouyanni, T. Bellander, M. Grau, W. Koenig, T. Lanki, R. Pistelli, A. Schneider, A. Peters, et al.
Mediterranean diet and inflammatory response in myocardial infarction survivors
Int. J. Epidemiol., June 1, 2009; 38(3): 856 - 866.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. Luciano, R. E. Marioni, A. J. Gow, J. M. Starr, and I. J. Deary
Reverse Causation in the Association Between C-Reactive Protein and Fibrinogen Levels and Cognitive Abilities in an Aging Sample
Psychosom Med, May 1, 2009; 71(4): 404 - 409.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Ruckerl, A. Peters, N. Khuseyinova, M. Andreani, W. Koenig, C. Meisinger, K. Dimakopoulou, J. Sunyer, T. Lanki, F. Nyberg, et al.
Determinants of the Acute-Phase Protein C-Reactive Protein in Myocardial Infarction Survivors: The Role of Comorbidities and Environmental Factors
Clin. Chem., February 1, 2009; 55(2): 322 - 335.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. J. Glynn, J. G. MacFadyen, and P. M Ridker
Tracking of High-Sensitivity C-Reactive Protein after an Initially Elevated Concentration: The JUPITER Study
Clin. Chem., February 1, 2009; 55(2): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
P. G. Surtees, N. W. J. Wainwright, S. M. Boekholdt, R. N. Luben, N. J. Wareham, and K.-T. Khaw
Major Depression, C-Reactive Protein, and Incident Ischemic Heart Disease in Healthy Men and Women
Psychosom Med, October 1, 2008; 70(8): 850 - 855.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Ruckerl, A. Ibald-Mulli, W. Koenig, A. Schneider, G. Woelke, J. Cyrys, J. Heinrich, V. Marder, M. Frampton, H. E. Wichmann, et al.
Air Pollution and Markers of Inflammation and Coagulation in Patients with Coronary Heart Disease
Am. J. Respir. Crit. Care Med., February 15, 2006; 173(4): 432 - 441.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
N. Sattar
High sensitivity C-reactive protein in cardiovascular disease and type 2 diabetes: evidence for a clinical role?
The British Journal of Diabetes & Vascular Disease, January 1, 2006; 6(1): 5 - 8.
[PDF]


Home page
Ann Rheum DisHome page
T Sturmer, E Raum, M Buchner, K Gebhardt, M Schiltenwolf, W Richter, and H Brenner
Pain and high sensitivity C reactive protein in patients with chronic low back pain and acute sciatic pain
Ann Rheum Dis, June 1, 2005; 64(6): 921 - 925.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. M. Stuveling, S. J. L. Bakker, H. L. Hillege, P. E. de Jong, R. O. B. Gans, and D. de Zeeuw
Biochemical risk markers: a novel area for better prediction of renal risk?
Nephrol. Dial. Transplant., March 1, 2005; 20(3): 497 - 508.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
P. Bogaty, J. M. Brophy, L. Boyer, S. Simard, L. Joseph, F. Bertrand, and G. R. Dagenais
Fluctuating Inflammatory Markers in Patients With Stable Ischemic Heart Disease
Arch Intern Med, January 24, 2005; 165(2): 221 - 226.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. O. Talbott, J. V. Zborowski, M. Y. Boudreaux, K. P. McHugh-Pemu, K. Sutton-Tyrrell, and D. S. Guzick
The Relationship between C-Reactive Protein and Carotid Intima-Media Wall Thickness in Middle-Aged Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6061 - 6067.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Bogaty, J. M. Brophy, M. Noel, L. Boyer, S. Simard, F. Bertrand, and G. R. Dagenais
Impact of Prolonged Cyclooxygenase-2 Inhibition on Inflammatory Markers and Endothelial Function in Patients With Ischemic Heart Disease and Raised C-Reactive Protein: A Randomized Placebo-Controlled Study
Circulation, August 24, 2004; 110(8): 934 - 939.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
P Z Hrycaj, T Sturmer, H Brenner, W Koenig, and K P Gunther
Systemic inflammation in osteoarthritis * Authors' reply
Ann Rheum Dis, June 1, 2004; 63(6): 750 - 751.
[Full Text]


Home page
CirculationHome page
P. M Ridker and N. Cook
Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores
Circulation, April 27, 2004; 109(16): 1955 - 1959.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. Danesh, J. G. Wheeler, G. M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G. D.O. Lowe, M. B. Pepys, and V. Gudnason
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
N. Engl. J. Med., April 1, 2004; 350(14): 1387 - 1397.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. J. MacGregor, J. R. Gallimore, T. D. Spector, and M. B. Pepys
Genetic Effects on Baseline Values of C-Reactive Protein and Serum Amyloid A Protein: A Comparison of Monozygotic and Dizygotic Twins
Clin. Chem., January 1, 2004; 50(1): 130 - 134.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
N. Khuseyinova, A. Imhof, G. Trischler, D. Rothenbacher, W. L. Hutchinson, M. B. Pepys, and W. Koenig
Determination of C-Reactive Protein: Comparison of Three High-Sensitivity Immunoassays
Clin. Chem., October 1, 2003; 49(10): 1691 - 1695.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.